• About
  • Archive
  • Contact
  • Home 1
  • Submit a Story
  • Submit a Story
  • USCBC Podcasts
China Business Review
  • Operations
    Managing Risk in the “New Era”

    Managing Risk in the “New Era”

    Design Patents vs. Trade Dress: Protecting IP in China

    Design Patents vs. Trade Dress: Protecting IP in China

    As China Emerges from COVID-19, US Companies Invest to Compete

    As China Emerges from COVID-19, US Companies Invest to Compete

    Inside the Mad Rush for Masks – Anatomy of a 10 Million Mask Order

    Inside the Mad Rush for Masks – Anatomy of a 10 Million Mask Order

    Addressing Risk in the Era of US-China “Great Power” Competition

    Addressing Risk in the Era of US-China “Great Power” Competition

    The Year in Social Credit: Where is Corporate Social Credit Going in 2020 and Beyond?

    The Year in Social Credit: Where is Corporate Social Credit Going in 2020 and Beyond?

  • Politics
    Hong Kong’s National Security Law, Five Months In

    Hong Kong’s National Security Law, Five Months In

    China Implements its Long-Awaited Unreliable Entities List Mechanism

    China Implements its Long-Awaited Unreliable Entities List Mechanism

    Competing WTO Reform Agendas and the Contest for the Next Director-General

    Competing WTO Reform Agendas and the Contest for the Next Director-General

    China Eyes Further Northeast Asian Economic Integration in RCEP

    China Eyes Further Northeast Asian Economic Integration in RCEP

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    A Game of Chicken

    A Game of Chicken

  • Tech
    Export Controls on Emerging and Foundational Technologies: A Null Set?

    Export Controls on Emerging and Foundational Technologies: A Null Set?

    How Companies Are Reacting to China’s New Data Security Scheme

    How Companies Are Reacting to China’s New Data Security Scheme

    China’s Participation in International Standards Setting: Benefits and Concerns for US Industry

    China’s Participation in International Standards Setting: Benefits and Concerns for US Industry

    The Hidden Challenges of China’s Booming Medical AI Market

    The Brave New Business Models Making Waves in China’s Ecommerce Market

    Defining “Emerging Technologies”: Industry Weighs In on Potential New Export Controls

    Defining “Emerging Technologies”: Industry Weighs In on Potential New Export Controls

    Trending Tags

    • Intellectual Property
    • innovation
    • cybersecurity
    • ecommerce
    • tech
  • Society
    COVID-19 Could Doom or Deliver US-China Commercial Relations

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    The Year in Social Credit: Where is Corporate Social Credit Going in 2020 and Beyond?

    The Year in Social Credit: Where is Corporate Social Credit Going in 2020 and Beyond?

    Open Government Developments in China: Implications for US Businesses

    The Hidden Challenges of China’s Booming Medical AI Market

    The Handshake that Changed the World

    President Carter and Vice Premier Deng at the Performance of American Arts

    January 29, 1979 Performance of American Arts for Deng Xiaoping

  • Media

    Gallery: Craig Allen’s Trip to China

    USCBC 45th Annual Membership Meeting

    USCBC 45th Anniversary DC Open House

    USCBC President’s China Visit

    USCBC Hosts Business Roundtable with Zhejiang Party Secretary Che Jun

    USCBC hosts Comprehensive Economic Dialogue (CED) Luncheon

  • Podcasts
No Result
View All Result
  • Operations
    Managing Risk in the “New Era”

    Managing Risk in the “New Era”

    Design Patents vs. Trade Dress: Protecting IP in China

    Design Patents vs. Trade Dress: Protecting IP in China

    As China Emerges from COVID-19, US Companies Invest to Compete

    As China Emerges from COVID-19, US Companies Invest to Compete

    Inside the Mad Rush for Masks – Anatomy of a 10 Million Mask Order

    Inside the Mad Rush for Masks – Anatomy of a 10 Million Mask Order

    Addressing Risk in the Era of US-China “Great Power” Competition

    Addressing Risk in the Era of US-China “Great Power” Competition

    The Year in Social Credit: Where is Corporate Social Credit Going in 2020 and Beyond?

    The Year in Social Credit: Where is Corporate Social Credit Going in 2020 and Beyond?

  • Politics
    Hong Kong’s National Security Law, Five Months In

    Hong Kong’s National Security Law, Five Months In

    China Implements its Long-Awaited Unreliable Entities List Mechanism

    China Implements its Long-Awaited Unreliable Entities List Mechanism

    Competing WTO Reform Agendas and the Contest for the Next Director-General

    Competing WTO Reform Agendas and the Contest for the Next Director-General

    China Eyes Further Northeast Asian Economic Integration in RCEP

    China Eyes Further Northeast Asian Economic Integration in RCEP

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    A Game of Chicken

    A Game of Chicken

  • Tech
    Export Controls on Emerging and Foundational Technologies: A Null Set?

    Export Controls on Emerging and Foundational Technologies: A Null Set?

    How Companies Are Reacting to China’s New Data Security Scheme

    How Companies Are Reacting to China’s New Data Security Scheme

    China’s Participation in International Standards Setting: Benefits and Concerns for US Industry

    China’s Participation in International Standards Setting: Benefits and Concerns for US Industry

    The Hidden Challenges of China’s Booming Medical AI Market

    The Brave New Business Models Making Waves in China’s Ecommerce Market

    Defining “Emerging Technologies”: Industry Weighs In on Potential New Export Controls

    Defining “Emerging Technologies”: Industry Weighs In on Potential New Export Controls

    Trending Tags

    • Intellectual Property
    • innovation
    • cybersecurity
    • ecommerce
    • tech
  • Society
    COVID-19 Could Doom or Deliver US-China Commercial Relations

    COVID-19 Could Doom or Deliver US-China Commercial Relations

    The Year in Social Credit: Where is Corporate Social Credit Going in 2020 and Beyond?

    The Year in Social Credit: Where is Corporate Social Credit Going in 2020 and Beyond?

    Open Government Developments in China: Implications for US Businesses

    The Hidden Challenges of China’s Booming Medical AI Market

    The Handshake that Changed the World

    President Carter and Vice Premier Deng at the Performance of American Arts

    January 29, 1979 Performance of American Arts for Deng Xiaoping

  • Media

    Gallery: Craig Allen’s Trip to China

    USCBC 45th Annual Membership Meeting

    USCBC 45th Anniversary DC Open House

    USCBC President’s China Visit

    USCBC Hosts Business Roundtable with Zhejiang Party Secretary Che Jun

    USCBC hosts Comprehensive Economic Dialogue (CED) Luncheon

  • Podcasts
No Result
View All Result
China Business Review
No Result
View All Result
Home Policy & Regulations

Tackling a Mountain of Applications: The CFDA’s New Plans to Accelerate the Review Process for Medical Devices

USCBC by USCBC
September 14, 2016
Share on FacebookShare on TwitterLinkedin

By Dezan Shira & Associates

On June 20, China’s Food and Drug Administration (“CFDA”) proposed the Priority Review Designation Procedure for Medical Devices (Exposure Draft) in an effort to cut through persistent bureaucratic red tape in the medical devices registration process and fulfill China’s rising clinical demand for medical devices.

The Exposure Draft was released after the State Council’s published the “Opinions on the Reform of Review and Approval System for Drugs and Medical Devices” in 2015, which focused on the inefficiency of the medical device approval process. In response, the CFDA proposed a new approval mechanism – Priority Review Designation Procedure– and drafted the eligibility, application, and opposition procedures, as well as other requirements for joining the special treatment.

Priority Review Designation

According to the Exposure Draft, the procedure is limited to medical devices categorized as domestic Class III, imported Class II, or imported Class III. China’s classification regime is based on the risk that a device presents to patients, with Class III reserved for the riskiest, yet most sophisticated devices, such as heart valve prosthesis. Therefore, medical devices categorized as Class III usually go through more costly and time-consuming examination procedures than other classes.

Exclusive to high-end medical devices, the procedure requires these devices satisfy one of the following conditions to be eligible for the Priority Review Designation: enrollment in the National Science and Technology Major Project or National Key Research and Development Plan, or fulfillment of any of the following conditions:

  • Able to diagnose or treat rare diseases, with outstanding clinical advantages;
  • Able to diagnose or treat malignant tumors, with outstanding clinical advantages;
  • Able to diagnose or treat specific and frequently occurring diseases in the elderly, and where there is no effective way to diagnose or treat such diseases at the moment;
  • Able to diagnose or treat specific and frequently occurring diseases in children, and where there is no effective way to diagnose or treat such diseases at the moment; and
  • Able to address an urgent clinical demand while similar medical devices have not been registered in China yet.

The CFDA will seek advice from professionals and grant priority review to other medical devices if necessary.

medical-device-approval-flow-chart

Overview of China’s Medical Devices Industry

The medical device market in China witnessed tremendous growth during the past decade. Sales of medical devices exceeded RMB308 billion in 2015, up more than 50 percent from the previous year. A number of socio-economic factors will continue to drive expansion of China’s medical devices market, including:

  • Aging society: According to the National Bureau of Statistics, China’s elderly population aged 60 and over reached 222 million in 2015, accounting for 1 percent of the country’s total population. The share of Chinese senior citizens is projected to grow to 35 percent by the end of 2050, according to the World Health Organization. With this rapidly expanding aging population, the medical device industry in China is poised for a sustained period of rapid growth.
  • Rising living standards: The per capita disposable income of Chinese urban residents has substantially increased from RMB10,493 in 2005 to RMB31,195 in 2015, according to the National Bureau of Statistics. Improved purchasing power has made health investment more affordable for almost every household in China, further spurring the demand for medical devices.
  • Lopsided market structure: Compared to developed countries, where public spending on medicines and medical devices is roughly equal in size, China favors medicine treatment over medical devices; the market for medical devices is only 14 percent of that for medicine, leaving a large part of the market underserved. If this dynamic changes, as many believes it will, the medical devices market will see another up-cycle.
Long Journey to Reform

Despite myriad opportunities attracting medical device manufacturers and suppliers, the application for medicines and medical devices stacks up on regulatory agents’ desks in the CFDA. In 2015, 21,000 applications were under examination, marking the third peak since 2005, according to CFDA officials. Some medical device companies denounce the standard registration process, which can take up to eight years under the current approval system, arguing that the review process prevents them from entering the market.

China has come a long way in reducing medical devices registration processing time, aiming to make more advanced technologies and devices accessible for the interest of public health.

There are two fast-track review procedures already in effect. In 2009, the CFDA enacted an expedited review process for medical devices applicable to emergency public health incidents. For instance, in an effort to prevent further dissemination of the Zika Virus in China, earlier this year the CFDA granted an accelerated review process for the Zika Virus Test Kit, a technology developed by a domestic medical company called Tianlong. Another fast track approval process was designated for innovative medical devices which must be the first of its kind in China. The intellectual property of the medical device must be acquired in China, however.

Moreover, the CFDA revised its “Regulations on the Supervision and Administration of Medical Devices,” the highest level regulations governing the registration, manufacture, and distribution of medicines and medical devices, and supervising all types of illegal market behaviors. The Regulations stipulate that manufacturers of Class I medical devices only need to submit filings instead of registrations to the CFDA, which will potentially lead to shorter wait times for approval. Furthermore, the CFDA plans to squeeze the initial review of Class II devices to 60 days and Class III devices to 90 days, but these timeframes seem unlikely when external expert reviews or combination device-medicine reviews are involved.

Once enacted, the Priority Review Designation Procedure will be the third streamlined review program. While this can be exciting news for medical device developers and manufacturers, there still remains some uncertainties in the Exposure Draft, such as how much time the procedure can realistically reduce during the approval process. 

With the Exposure Draft already closed to public comment, the official rules from the CFDA are expected to be released soon.

 

This piece originally appeared on Asia Briefing Ltd., a subsidiary of Dezan Shira & Associates. Dezan Shira is a specialist foreign direct investment practice, providing corporate establishment, business advisory, tax advisory and compliance, accounting, payroll, due diligence and financial review services to multinationals investing in China, Hong Kong, India, Vietnam, Singapore and the rest of ASEAN. For further information, please email [email protected] or visitwww.dezshira.com.

USCBC

USCBC

Next Post

Inflicting Loss on Investors through Cooked Books: Assessing Accounting Fraud in China

Recommended.

How Biden’s Economic Team Views China Trade Policy

January 14, 2021

Hong Kong’s National Security Law, Five Months In

November 25, 2020

China Implements its Long-Awaited Unreliable Entities List Mechanism

October 7, 2020

Competing WTO Reform Agendas and the Contest for the Next Director-General

September 22, 2020

Latest Podcasts.

A look at China’s recent spate of bond defaults

January 22, 2021

A COVID update, a record trade surplus, and new PRCG personnel

January 19, 2021

New MOFCOM rules on extraterritorial application of foreign laws

January 12, 2021

The EU-China agreement and a look at other market liberalizations

January 6, 2021
China Business Review

China Business Review is the official magazine of the US-China Business Council, a nonprofit and nonpartisan trade association that represents more than 200 American companies doing business in China.

  • How to contribute to China Business Review

Categories

  • Bilateral Relations
  • Business Etiquette
  • CBR Spotlight
  • China Deals
  • Corruption
  • Cybersecurity
  • Ecommerce
  • Environment
  • Finance
  • Galleries
  • Getting Started
  • HR & Staffing
  • Infographics
  • Innovation
  • Intellectual Property
  • Management
  • Media
  • Operations
  • Opinion
  • Policy & Regulations
  • Politics
  • PR & Marketing
  • Rural Issues
  • Safety
  • Social Policy
  • Society
  • Standards + Licensing
  • Sustainability
  • Tax
  • Tech
  • Top Story
  • Trade
  • Uncategorized
  • US-China Business Council
  • Videos

Tags

Agreements Agriculture Alibaba Best Practices Business Environment China China's Investments Abroad China Market Intelligence Chinese Consumers Chinese Investment Commentary Consumer Trends E-Commerce Economic Trends Energy Environment Events Food Foreign Investment Going Global Healthcare Reform Human Resources Infrastructure Internet Interview Investment Investments into China IPO Joint Venture Labor Legal Analysis M&A Manufacturing Media National People's Congress Q&A Strategic and Economic Dialogue Supply Chains Technology Trade Transparency US-China Relations USCBC US Exports to China Xi Jinping

Join our Mailing List

Sign up for the US-China Business Council's newsletters to stay ahead of the game with roundups, analysis, and commentary.

Sign Up

Follow Us

  • About
  • Archive
  • Contact
  • Home 1
  • Submit a Story
  • Submit a Story
  • USCBC Podcasts

© 2020 China Business Review

No Result
View All Result
  • Operations
  • Politics
  • Tech
  • Society
  • Media
  • Podcasts

© 2020 China Business Review